Atara Biotherapeutics, Inc.
ATRANasdaqCIK 1604464HealthcareFiscal year ends Dec 31
Reports and events: 229 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-11-1216:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125389 |
| 2024-11-1216:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-125334 |
| 2024-10-1516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-237582 |
| 2024-09-0516:07 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-097369 |
| 2024-09-0317:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-212168 |
| 2024-08-1217:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-095533 |
| 2024-08-1217:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-095526 |
| 2024-07-1716:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-180371 |
| 2024-06-2017:04 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-164554 |
| 2024-06-1708:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-162069 |
| 2024-06-1117:32 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-158461 |
| 2024-05-2218:18 ET | SC 13D | Ownership report, active investor | 0001104659-24-064358 |
| 2024-05-0916:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056959 |
| 2024-05-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056901 |
| 2024-04-2616:15 ET | DEF 14A | Proxy statementPeriod 2024-06-10 | 0000950170-24-049147 |
| 2024-03-2916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-038690 |
| 2024-03-2808:40 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-037644 |
| 2024-03-2808:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-037643 |
| 2024-02-2316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-019416 |
| 2024-01-0916:01 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001193125-24-005188 |
| 2024-01-0808:11 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-003945 |
| 2023-12-2016:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-071896 |
| 2023-11-0921:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-273808 |
| 2023-11-0116:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-268185 |
| 2023-11-0108:40 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-057147 |
| 2023-11-0108:35 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000950170-23-057146 |
| 2023-09-2018:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-237762 |
| 2023-08-0816:13 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039820 |
| 2023-08-0816:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039797 |
| 2023-06-0916:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-027257 |
| 2023-06-0516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000950170-23-026351 |
| 2023-05-1216:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-021809 |
| 2023-05-0816:14 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-018820 |
| 2023-05-0816:06 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-018793 |
| 2023-04-0716:30 ET | DEF 14A | Proxy statement | 0000950170-23-012204 |
| 2023-03-3116:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-011416 |
| 2023-03-1016:21 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-23-067628 |
| 2023-02-0816:54 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-002185 |
| 2023-02-0816:02 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-002132 |
| 2023-01-0616:16 ET | 8-K | 2.03 New direct financial obligation | 0001193125-23-003555 |
| 2022-12-2016:42 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-22-309181 |
| 2022-12-1908:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-22-307898 |
| 2022-11-0816:20 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-023248 |
| 2022-11-0816:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-023226 |
| 2022-09-2816:30 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-22-253304 |
| 2022-09-2716:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-252141 |
| 2022-08-0816:14 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-015536 |
| 2022-08-0816:07 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-22-015519 |
| 2022-06-2416:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-181461 |
| 2022-05-1916:05 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-22-155021 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 02:48 ET. Listed shows no prices and gives no investment advice.